New Hormone Therapy Message Board Offers A Discussion Forum For Patients

Share Article

The law firm of Hissey Kientz, LLP wishes to announce the launch of its new Hormone Replacement Therapy Message Board (hrtboard.com/). The site will serve as a forum for hormone therapy users to share comments, read about the cases of other hormone therapy patients and answer frequently asked questions about hormone therapy.

News Image

The law firm of Hissey Kientz, LLP wishes to announce the launch of its new Hormone Replacement Therapy Message Board (hrtboard.com/). The site will serve as a forum for hormone therapy users to share comments, read about the cases of other hormone therapy patients and answer frequently asked questions about hormone therapy.

Hormone therapy drugs are designed to relieve menopausal symptoms including hot flashes and night sweats by replacing the hormones that are lost as women enter menopause. Early hormone therapy drugs like Premarin were estrogen-only medications. When scientists discovered that unopposed estrogen had caused an endometrial cancer crisis, doctors begin prescribing synthetic progesterone called “progestin” and “MPA” to be used with estrogen to protect the endometrial lining of the uterus. The principal progestin sold was Provera. Eventually, Wyeth began selling estrogen (“E”) and progestin (“P”) in a single pill.

In 2002, the Women’s Health Initiative study (“WHI”) conducted by the National Institutes of Health was abruptly halted after researchers found that women taking E+P faced increased risk of developing breast cancer as well as heart attacks, strokes and blood clots, among other injuries.

After the WHI study, millions of women stopped taking hormone therapy. Within just a year, breast cancer rates declined dramatically. The decline was focused in postmenopausal women and involved almost exclusively hormone receptor-positive cance –the very tumors fueled by hormone therapy. Dozens of studies now confirm the relationship between E+P and breast cancer.

These revelations came too late for many women. Thousands of breast cancer victims have sued Wyeth, Upjohn and other makers of E+P drugs, alleging that these companies failed to properly warn women about the breast cancer risks associated with their products.

One such user, Donna Scroggin, was treated with hormone therapy for 11 years before being diagnosed with breast cancer. Due to the seriousness of her condition, Ms. Scroggin was forced to undergo a double mastectomy and have the lymph nodes beneath her arms removed. In 2004, Ms. Scroggin sued Wyeth and Upjohn, claiming their drugs caused her cancer. The jury agreed with Ms. Scroggin, awarding her compensatory and punitive damages.

To learn more about Donna Scroggin and other women who have developed breast cancer after using hormone therapy, or to share your own experiences with HRT, please visit the Hormone Replacement Therapy Message Board at hrtboard.com/.

About Hissey Kientz, LLP
Hissey Kientz, LLP represents victims of hormone therapy drugs including Prempro, Premarin and Provera, as well as those who have suffered mesothelioma and other asbestos diseases, side effects of Yaz, Yasmin or Ocella birth control, Duragesic or fentanyl overdose deaths, acute phosphate nephropathy as a result of Fleet Phospho-soda bowel cleansing products, Digitek, Zicam, the Composix Kugel mesh patch, gadolinium MRI contrast dyes, Reglan, FELA railroad injury lawsuits, the Ortho Evra birth control patch and primary pulmonary hypertension (PPH) caused by Fen-Phen, as well as other defective drugs and devices. To learn more about the law firm and other drug cases, visit us online or call toll-free at (866) 275-4454.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Craig Whitney
Visit website